Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 3 de 3
Filtrar
Mais filtros











Intervalo de ano de publicação
1.
Int. braz. j. urol ; 42(5): 1018-1027, Sept.-Oct. 2016. tab, graf
Artigo em Inglês | LILACS | ID: lil-796875

RESUMO

ABSTRACT Objective: To evaluate the effect of neuronal nitric oxide synthase on the striated urethral sphincter and the urinary bladder. Materials and Methods: A coaxial catheter was implanted in the proximal urethra and another one in the bladder of female rats, which were anesthetized with subcutaneous injection of urethane. The urethral pressure with saline continuous infusion and bladder isovolumetric pressure were simultaneously recorded. Two groups of rats were formed. In group I, an intrathecal catheter was implanted on the day of the experiment at the L6-S1 level of the spinal cord; in group II, an intracerebroventricular cannula was placed 5-6 days before the experiment. Results: It was verified that the group treated with S-methyl-L-thio-citrulline, via intrathecal pathway, showed complete or partial inhibition of the urethral sphincter relaxation and total inhibition of the micturition reflexes. The urethral sphincter and the detrusor functions were recovered after L-Arginine administration. When S-methyl-L-thio-citrulline was administered via intracerebroventricular injection, there was a significant increase of urethral sphincter tonus while preserving the sphincter relaxation and the detrusor contractions, at similar levels as before the use of the drugs. Nevertheless there was normalization of the urethral tonus when L-Arginine was applied. Conclusions: The results indicate that, in female rats anaesthetized with urethane, the nNOS inhibitor administrated through the intrathecal route inhibits urethral sphincter relaxation, while intracerebroventricular injection increases the sphincter tonus, without changing bladder function. These changes were reverted by L-Arginine administration. These findings suggest that the urethral sphincter and detrusor muscle function is modulated by nitric oxide.


Assuntos
Animais , Feminino , Tioureia/análogos & derivados , Uretra/efeitos dos fármacos , Micção/efeitos dos fármacos , Bexiga Urinária/efeitos dos fármacos , Citrulina/análogos & derivados , Inibidores Enzimáticos/farmacologia , Óxido Nítrico Sintase Tipo I/farmacologia , Arginina/farmacologia , Pressão , Valores de Referência , Tioureia/farmacologia , Fatores de Tempo , Uretana/farmacologia , Uretra/fisiologia , Micção/fisiologia , Bexiga Urinária/fisiologia , Injeções Espinhais , Citrulina/farmacologia , Ratos Wistar , Anestésicos Intravenosos , Contração Muscular/efeitos dos fármacos , Contração Muscular/fisiologia
2.
An Acad Bras Cienc ; 88 Suppl 1: 609-22, 2016.
Artigo em Inglês | MEDLINE | ID: mdl-27142540

RESUMO

The objective of this study was to investigate the effects of 2% L-glutamine supplementation on myenteric innervation in the ileum of diabetic rats, grouped as follows: normoglycemic (N); normoglycemic supplemented with L-glutamine (NG); diabetic (D); and diabetic supplemented with L-glutamine (DG). The ileums were subjected to immunohistochemical techniques to localize neurons immunoreactive to HuC/D protein (HuC/D-IR) and neuronal nitric oxide synthase enzyme (nNOS-IR) and to analyze varicosities immunoreactive to vasoactive intestinal polypeptide (VIP-IR) and calcitonin gene-related peptide (CGRP-IR). L-Glutamine in the DG group (i) prevented the increase in the cell body area of nNOS-IR neurons, (ii) prevented the increase in the area of VIP-IR varicosities, (iii) did not prevent the loss of HuC/D-IR and nNOS-IR neurons per ganglion, and (iv) reduced the size of CGRP-IR varicosities. L-Glutamine in the NG group reduced (i) the number of HuC/D-IR and nNOS-IR neurons per ganglion, (ii) the cell body area of nNOS-IR neurons, and (iii) the size of VIP-IR and CGRP-IR varicosities. 2% L-glutamine supplementation exerted differential neuroprotective effects in experimental diabetes neuropathy that depended on the type of neurotransmitter analyzed. However, the effects of this dose of L-glutamine on normoglycemic animals suggests there are additional actions of this beyond its antioxidant capacity.


Assuntos
Diabetes Mellitus Experimental , Glutamina/farmacologia , Íleo/inervação , Plexo Mientérico/efeitos dos fármacos , Animais , Peptídeo Relacionado com Gene de Calcitonina/farmacologia , Corpo Celular/efeitos dos fármacos , Glutamina/administração & dosagem , Imuno-Histoquímica , Neurônios/efeitos dos fármacos , Neurônios Nitrérgicos , Óxido Nítrico Sintase Tipo I/farmacologia , Ratos , Ratos Wistar , Peptídeo Intestinal Vasoativo/farmacologia
3.
Int Braz J Urol ; 42(5): 1018-1027, 2016.
Artigo em Inglês | MEDLINE | ID: mdl-24893916

RESUMO

OBJECTIVE: To evaluate the effect of neuronal nitric oxide synthase on the striated urethral sphincter and the urinary bladder. MATERIALS AND METHODS: A coaxial catheter was implanted in the proximal urethra and another one in the bladder of female rats, which were anesthetized with subcutaneous injection of urethane. The urethral pressure with saline continuous infusion and bladder isovolumetric pressure were simultaneously recorded. Two groups of rats were formed. In group I, an intrathecal catheter was implanted on the day of the experiment at the L6-S1 level of the spinal cord; in group II, an intracerebroventricular cannula was placed 5-6 days before the experiment. RESULTS: It was verified that the group treated with S-methyl-L-thio-citrulline, via intrathecal pathway, showed complete or partial inhibition of the urethral sphincter relaxation and total inhibition of the micturition reflexes. The urethral sphincter and the detrusor functions were recovered after L-Arginine administration. When S-methyl-Lthio-citrulline was administered via intracerebroventricular injection, there was a significant increase of urethral sphincter tonus while preserving the sphincter relaxation and the detrusor contractions, at similar levels as before the use of the drugs. Nevertheless there was normalization of the urethral tonus when L-Arginine was applied. CONCLUSIONS: The results indicate that, in female rats anaesthetized with urethane, the nNOS inhibitor administrated through the intrathecal route inhibits urethral sphincter relaxation, while intracerebroventricular injection increases the sphincter tonus, without changing bladder function. These changes were reverted by L-Arginine administration. These findings suggest that the urethral sphincter and detrusor muscle function is modulated by nitric oxide.


Assuntos
Citrulina/análogos & derivados , Inibidores Enzimáticos/farmacologia , Óxido Nítrico Sintase Tipo I/farmacologia , Tioureia/análogos & derivados , Uretra/efeitos dos fármacos , Bexiga Urinária/efeitos dos fármacos , Micção/efeitos dos fármacos , Anestésicos Intravenosos , Animais , Arginina/farmacologia , Citrulina/farmacologia , Feminino , Injeções Espinhais , Contração Muscular/efeitos dos fármacos , Contração Muscular/fisiologia , Pressão , Ratos Wistar , Valores de Referência , Tioureia/farmacologia , Fatores de Tempo , Uretana/farmacologia , Uretra/fisiologia , Bexiga Urinária/fisiologia , Micção/fisiologia
SELEÇÃO DE REFERÊNCIAS
DETALHE DA PESQUISA